Cyano Pharma Private Limited, a active private limited company, was established on 29 February 2000 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MH2000PTC283629. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.94 M.
It upholds a compliant status. Employing 36 professional, Its leadership includes Sureshchandra Chourasiya (Director), Mahendra Patidar (Director). Past directors included Vijay Kumar Jain, Devendra Joshi, Sureshchandra Chourasiya. It holds ₹40.49 Cr open charges and ₹2.39 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 6 Gr. Floor, Patnawala Compound, Opp. Shreyas Lbs Marg, Ghatkopar (W), Mumbai, Maharashtra, 400086.
U24232MH2000PTC283629
283629
29 February 2000
₹5.00 M
₹4.94 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Cyano Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sureshchandra Chourasiya | Director | 01 Sep 2010 | Current |
| Mahendra Patidar | Director | 10 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Apr 2018 | Past |
| Pramod Abcsdd | Director | 30 Jun 2014 | Past |
| Pramod Abcsdd | Additional Director | 25 Aug 2011 | Past |
| Pramod Abcsdd | Additional Director | 11 Mar 2025 | Past |
| Pramod Abcsdd | Additional Director | 20 May 2015 | Past |
| Pramod Abcsdd | Director | 19 May 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cyano Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.16% increase. The company also saw a slight decrease in profitability, with a 9.94% decrease in profit. The company's net worth moved up by a moderate rise of 5.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Cyano Pharma had a promoter holding of 7.35% and a public holding of 92.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹404,900,000.00
₹23,870,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2023 | Sidbi | ₹2.18 Cr | Open |
| 19 Oct 2020 | State Bank Of India | ₹1.70 M | Open |
| 05 Mar 2004 | State Bank Of India | ₹38.14 Cr | Open |
| 08 Oct 2024 | Others | ₹1.00 M | Satisfied |
| 01 Jun 2020 | State Bank Of India | ₹9.40 M | Satisfied |
Explore comprehensive loan charge details -
Cyano Pharma has a workforce of 36 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cyano Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyano Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Cyano Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
A charge with State Bank Of India of Rs. 381.40 M registered on 05 Mar 2004 with Charge ID 90204135 was modified on 22 Sep 2025. was recorded as a recent event.
A charge registered on 08 Oct 2024 via Charge ID 101019838 with Others was fully satisfied on 08 Jul 2025. was recorded as a recent event.
Cyano Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
A charge with Others amounted to Rs. 1.00 M with Charge ID 101019838 was registered on 08 Oct 2024. was recorded as a recent event.
Mahendra Patidar was appointed as a Director was appointed as a Director on 10 Mar 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.
The CIN of Cyano Pharma Private Limited is U24232MH2000PTC283629.
Cyano Pharma Private Limited is headquartered at 6 Gr. Floor, Patnawala Compound, Opp. Shreyas Lbs Marg, Ghatkopar (W), Mumbai, Maharashtra, 400086.
Cyano Pharma Private Limited was incorporated on 29 February 2000.
The current directors of Cyano Pharma Private Limited are
The primary industry of Cyano Pharma Private Limited is Manufacturing.
Cyano Pharma Private Limited is unlisted.
The authorized capital of Cyano Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹4.94 M.
The compliance status of Cyano Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX